Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Zafgen Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Zafgen Inc. - Product Pipeline Review - 2014', provides an overview of the Zafgen Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Zafgen Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Zafgen Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Zafgen Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Zafgen Inc.'s pipeline products Reasons to buy - Evaluate Zafgen Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Zafgen Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Zafgen Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Zafgen Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zafgen Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Zafgen Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Zafgen Inc. Snapshot 4 Zafgen Inc. Overview 4 Key Information 4 Key Facts 4 Zafgen Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Zafgen Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Zafgen Inc. - Pipeline Products Glance 11 Zafgen Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Zafgen Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Zafgen Inc. - Drug Profiles 13 beloranib 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Drug to Inhibit Methionine Aminopeptidase 2 for Obesity 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 fumagillin 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 ZGN-839 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Zafgen Inc. - Pipeline Analysis 19 Zafgen Inc. - Pipeline Products by Target 19 Zafgen Inc. - Pipeline Products by Route of Administration 20 Zafgen Inc. - Pipeline Products by Molecule Type 21 Zafgen Inc. - Pipeline Products by Mechanism of Action 22 Zafgen Inc. - Recent Pipeline Updates 23 Zafgen Inc. - Dormant Projects 26 Zafgen Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables Zafgen Inc., Key Information 4 Zafgen Inc., Key Facts 4 Zafgen Inc. - Pipeline by Indication, 2014 6 Zafgen Inc. - Pipeline by Stage of Development, 2014 7 Zafgen Inc. - Monotherapy Products in Pipeline, 2014 8 Zafgen Inc. - Partnered Products in Pipeline, 2014 9 Zafgen Inc. - Partnered Products/ Combination Treatment Modalities, 2014 10 Zafgen Inc. - Phase II, 2014 11 Zafgen Inc. - Preclinical, 2014 12 Zafgen Inc. - Pipeline by Target, 2014 19 Zafgen Inc. - Pipeline by Route of Administration, 2014 20 Zafgen Inc. - Pipeline by Molecule Type, 2014 21 Zafgen Inc. - Pipeline Products by Mechanism of Action, 2014 22 Zafgen Inc. - Recent Pipeline Updates, 2014 23 Zafgen Inc. - Dormant Developmental Projects,2014 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.